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ABSTRACT 
 
 
Melatonin Modulates Intercellular Communication among Immortalized Rat 
Suprachiasmatic Nucleus Cells.  (December 2007) 
Kimberly Yvonne Cox, B.S., University of Houston-Clear Lake 
Chair of Advisory Committee:  Dr. Mark J. Zoran 
 
 
The mammalian brain contains a regulatory center in the diencephalic region known as 
the hypothalamus that plays a critical role in physiological homeostasis, and contains a 
variety of centers for behavioral drives, such as hunger and thirst.  Located deep within 
the hypothalamus is the suprachiasmatic nucleus (SCN), or the master biological clock, 
that organizes rhythmic physiology and behavior, such that critical events take place at 
the most appropriate time of the day or night and in the most appropriate temporal, phase 
relationships.  Cell-to-cell communication is essential for conveying inputs to and 
outputs from the SCN.  The goal of the present study was to use an immortalized neural 
cell line (SCN2.2), derived from the presumptive anlage of the rat suprachiasmatic 
nucleus, as an in vitro model system to study intercellular communication among SCN 
cells.  I tested whether the pineal neurohormone melatonin could modulate cell-to-cell 
signaling, via both dye coupling (gap junctional communication) and calcium waves 
(ATP-dependent gliotransmission).  I also tested whether extracellular ATP could 
influence the spread of calcium waves in SCN2.2 cells.  Lastly, the ability of 
extracellular ATP to modulate SCN physiological responses to melatonin in SCN2.2 
cells was examined.   
 I show that melatonin at a physiological concentration (nM) reduced dye 
coupling (gap junctional communication) in SCN2.2 cells, as determined by a scrape 
loading procedure employing the fluorescent dye lucifer yellow.  Melatonin caused a 
significant reduction in the spread of calcium waves in cycling SCN2.2 cultures as 
determined by ratiometric calcium imaging with Fura-2 AM, a calcium sensitive 
indicator dye.  This reduction was greatest when an endogenous circadian rhythm in 
 iv
extracellular ATP accumulation, determined by luciferase assay, was at its trough or 
lowest extracellular concentration. In addition, melatonin and ATP interacted in the 
regulation of gliotransmission (calcium waves), and this interaction was also specific to 
particular phases of the endogenous SCN physiological rhythmicity.  Thus, I have 
established that a complex interaction exists between established melatonin signaling 
pathways and this newly discovered ATP accumulation rhythm, with the mechanisms 
underlying this relationship linked to endogenous cycling of SCN cellular physiology.  
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CHAPTER I 
INTRODUCTION 
 
Cellular processes governing how an animal’s physiology compensates for daily changes 
in environmental conditions are largely the product of specific neural structures. In these 
tissues, neural cells integrate sensory inputs into appropriate effector outputs. The 
coupling of inputs and outputs is typically orchestrated by neural oscillators that set the 
pace of physiological processes in the ultimate target tissue.  When these oscillatory 
mechanisms and their driven outputs are sustained in constant environmental conditions, 
i.e., in the absence of entraining sensory information, they are defined as biological 
clocks.  Additionally, if these oscillations possess a period of about (circa) a day (dian) 
when monitored under constant conditions, they are called circadian rhythms.  In this 
chapter, the critical features of circadian rhythm generation in mammals and the nervous 
system structures that govern them will be introduced.  In particular, a part of 
mammalian brain, the hypothalamus, and a specific kind of brain cell, the astrocyte, are 
of central importance to the research described in this thesis.  In addition, the cellular 
physiology regulating how these cells communicate and how that communication might 
be regulated by the biological clock lies at the heart of the hypotheses tested here. 
 
Mammalian hypothalamus 
The hypothalamus is a visceral control center located just beneath the thalamus in the 
diencephalic region of the mammalian brain and serves as the primary link between the 
nervous and endocrine systems (Martini et al., 2000a).  Although the hypothalamus 
occupies less than 1% of the total human brain volume, it contains a variety of centers 
for behavioral drives, such as hunger and thirst, and plays an important role in 
physiological homeostasis.  Neural outputs from the hypothalamus control many 
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functions of the autonomic division of the nervous system as well as an assortment of 
endocrine functions.  Functions of the hypothalamus include: activation of the 
sympathetic nervous system (as in fight-or-flight response), maintenance of body 
temperature, control of body osmolarity, control of reproductive functions, control of 
food intake, interaction with the limbic system to influence behavior and emotions, 
secretion of trophic factors that control the release of hormones from the anterior 
pituitary gland, and influence over the cardiovascular control center in the medulla 
oblongata.  The hypothalamus receives input from multiple sources, which include 
various sensory receptors, the reticular formation, and the cerebral cortex.  Its outputs 
project to the thalamus and ultimately to multiple effector pathways, which are mostly 
bidirectional.  One exception is the unidirectional, ascending pathway that leads from the 
retina to the suprachiasmatic nucleus, or SCN (Silverthorn, 2001a). 
 In mammals, photoreception takes place only in the retinae of the eyes (Dunlap 
et al., 2004b).  Light enters the eye and is perceived by photoreceptors in the retina.  
Visual information is sent via retinal ganglion cells’ axons of the optic nerve, which 
synapse in the lateral geniculate nucleus of the thalamus.  The neurons of the thalamus 
then project to the visual cortex of the occipital lobe (Silverthorn, 2001b), where visual 
information is integrated for association and cognition.  Collaterals of this visual 
retinothalamic pathway connect to two nuclei located in the hypothalamus and midbrain, 
which include the suprachiasmatic nucleus and the superior colliculus, respectively.  The 
superior colliculus integrates visual information with other sensory inputs (Martini et al., 
2000b).  The retinal ganglion cell pathway to the hypothalamus is called the 
retinohypothalamic tract (RHT) and terminates in the SCN.  The suprachiasmatic 
nucleus is the chief circadian pacemaker and regulates physiological processes under 
biological clock control in mammals (Klein and Moore, 1979).   
 
Suprachiasmatic nucleus 
The mammalian SCN is located just above the optic chiasm, where the crossing optic 
tracts arrive at the anterior ventral hypothalamus of the brain.  It consists of two small, 
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densely packed clusters of neural cells.  Each bilateral cluster contains about 10,000 
neuronal cells, along with an abundance of glial cells, primarily astrocytes, and 
fibroblasts.  Photoperiod inputs to the SCN entrain or set the phase of the biological 
clock, thereby allowing an organism to anticipate environmental opportunities for 
behavior and physiology.  The circadian clock organizes effector outputs to take place at 
the most appropriate time of the day or night and in appropriate phase relationships.  
Metabolism in diurnal mammals, for example, switches between processes that support 
psychological alertness and energetic demand (diurnal processes) and those involved in 
growth and repair of the body (nocturnal processes; Dunlap et al., 2004a). 
Circadian physiology of the SCN can be studied using in vitro cell culture.  
Model cell culture systems, like the SCN2.2 system used here, have been developed 
through an immortalization technique.  This process employs gene transfer techniques to 
mediate the introduction of an oncogene and expression of its immortalizing protein 
product in primary SCN cells (Dunlap et al., 2004b).  The SCN2.2 cell line was created 
from primary cultured cells of the presumptive anlage of the rat suprachiasmatic nucleus, 
which were immortalized by infection with a retroviral vector encoding the adenovirus 
12S E1A gene.  The resulting neural cell line consisted of a heterogeneous (astrocytes, 
neurons, and fibroblasts) population of cells in various stages of differentiation, although 
a large portion (≈75-90% of colony total) of the SCN2.2 cell line was characterized by 
glial-like morphology (Earnest et al., 1999a).  These immortalized SCN cells were 
capable of endogenously generating circadian rhythms in 2-deoxyglucose (2-DG) uptake 
(Earnest, et al., 1999b), canonical clock gene expression (Allen et al., 2001), and 
neurotrophin content (Earnest et al., 1999b).  The phase relationship between 2-DG 
uptake and neurotrophin content in vitro was identical to that exhibited by the SCN in 
vivo.  That is, a 12-hour antiphase relationship was exhibited between the rhythms of 
glucose utilization and brain-derived neurotrophic factor (BDNF) content in 
immortalized SCN cells.  Similarly, the rat SCN in vivo has been characterized by 
maximal 2-DG uptake at circadian time (CT) 6, or subjective day (Schwartz, 1991), and 
peak BDNF content around CT 18, or subjective night (Liang et al., 1998).  Furthermore, 
 4
transplantation of SCN2.2 cells into arrhythmic, SCN-lesioned rats restored circadian 
activity rhythms.  Where as, transplantation of mesencephalic or fibroblast cell lines did 
not restore the circadian activity rhythm.  Thus, these immortalized SCN progenitors 
retain the oscillator, pacemaker, and clock-control properties of the SCN and maintain 
these properties in appropriate circadian phase relationships (Earnest et al., 1999b). 
One goal of the present study is to establish the SCN2.2 cell line as a suitable in 
vitro model system for the study of intercellular communication among mammalian 
neural, clock-control elements.  Since individual cells of the SCN are competent 
circadian oscillators and together they function as an organismal physiology pacemaker, 
it is important to understand how these cells communicate with each other within the 
hypothalamus.  Cell-to-cell communication is essential for integration of inputs to and 
outputs from the SCN.  Signaling pathways by which the oscillatory cells of the SCN 
communicate may involve: 1) classical neurotransmitters, such as γ-aminobutyric acid 
(GABA; Decavel and Van den Pol, 1990), as intercellular coupling agents, 2) 
neuropeptides, such as arginine vasopressin and vasoactive intestinal peptide (AVP, VIP, 
respectively; Card et al., 1988), as coupling molecules, 3) gases, like nitric oxide (NO; 
Amir et al., 1995), that readily cross biological membranes and alter the biochemistry of 
surrounding cells, 4) electrical coupling via intercellular gap junctions (Colwell, 2000), 
and 5) complex glial-glial and glial-neuronal interactions involving gliotransmitters, 
such as glutamate and ATP (Michel and Colwell, 2001).   
Over the past decade, many insights have been gained into the complex 
interactions that occur between neurons and glia in the nervous system (Volterra et al., 
2002a).  A large number of synapses in the SCN, like those found in many brain regions 
such as the hippocampus (Volterra and Steinhäuser, 2004), are enveloped by astroglial 
processes.  Additionally, receptors for the pineal hormone melatonin are abundant on 
astrocytes of the SCN (Adachi et al., 2002; Rivera-Bermúdez et al., 2004). 
Consequently, glial cells, particularly astrocytes, may play a special role in regulating 
communication between populations of neurons in the SCN (Michel and Colwell, 2001).  
In the hypothalamus, astrocyte-neuron signaling is believed to regulate gonadotropin-
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releasing hormone (GnRH) production and secretion (Dhandapani et al., 2003).  The 
synaptic plasticity associated with GnRH neurons is modulated by hypothalamic 
astrocytes and may involve dynamic glial ensheathment, and the extension and retraction 
of glial processes (Witkin et al., 1995; Witkin et al., 1997). 
 
Astrocytic communication 
Hypothalamic astrocytes communicate intercellularly via gap junctions and 
gliotransmitter release (Welsh and Reppert, 1996; Batter et al., 1992; Blomstrand et al., 
1999; Pascual et al., 2005; Araque et al., 1999a; Araque et al., 1999b; Fig. 1).  The role 
that gap junctions play in intercellular communication has been well-documented in 
various tissues, including a wide range of functions in the brains of animals, where they 
act as gateways for the intercellular exchange of membrane currents, electrolytes, second 
messengers and metabolites.  In mammals, gap junctions are found in virtually every cell 
type except mature skeletal muscle, spermatozoa, and erythrocytes (Dermietzel and 
Spray, 1993), and in these diverse tissues- in both developmental and adult contexts- 
govern equally diverse biological events.   
Gap junctions are permeant to molecules as large as 1 kDa and are formed when 
two cells contribute a hemichannel composed of six membrane-spanning protein 
subunits called connexins.  These hemichannels, or membrane pores, become juxtaposed 
to generate a hydrophilic channel that plays a major role in cellular homeostasis, 
differentiation, and growth control by virtue of permitting transfer of regulatory and 
physiologically significant metabolites (Barhoumi et al., 1993).  However, gap 
junctional communication may not be an exclusively cell-to-cell process.  Recent work 
suggests that unapposed hemichannels, especially those formed of pannexin proteins, 
may permit the passage of molecules between the cytoplasm and extracellular 
surroundings (Ebihara, 2003; Goodenough and Paul, 2003).  Biochemical 
communication via gap junctions has been documented in epithelial cells (Sanderson et 
al., 1990) and neurons (Kandler and Katz, 1998).  In epithelial cells, inositol (1,4,5)-
trisphosphate (IP3) generated in a stimulated cell was able to spread to neighboring 
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electrically coupled cells via gap junctions (see Fig. 1A), where it caused a release of 
Ca2+ from intracellular stores (Sanderson et al., 1990).  Long-range signaling by Ca2+ 
waves, which involve elevations in intracellular Ca2+ concentration that propagate 
through a group of cells, has also been credited to astrocytic gap junctions (Nedergaard 
et al., 2003).  Astrocytic gap junctional communication contributes to the classical 
homeostatic functions these glial cells, such as:  1) transport of nutrients from the 
bloodstream to neurons, 2) ‘spatial buffering’ of K+ during neuronal excitation when K+ 
is released into the extracellular space and taken up by astrocytes, plus, 3) gap junctional 
mediated glutamate uptake and dissipation among astrocytes (Anderson et al., 2003). 
  Hypothalamic astrocytes also communicate via gliotransmitter release (Fig. 1B).  
Astrocytes express calcium excitability, which means that they possess mechanisms for 
the Ca2+-dependent release of chemical transmitters such as glutamate and ATP.  Just as 
neurons express excitability as a function of plasma membranes equipped with many 
voltage-gated ion channels that allow membrane depolarization and the propagation of 
action potentials, glial cells express this Ca2+-based form of excitability (Charles, 2005).  
Glial cells use an intracellular route to raise Ca2+ levels, employing intracellular 
organelles, specifically the endoplasmic reticulum (ER) and mitochondria.  These 
organelles generate and maintain intracellular, as well as intercellular, Ca2+ waves 
(Volterra et al., 2002b).  A characteristic property of astrocytes grown in cell culture is 
that a Ca2+ rise in one cell leads to a Ca2+ rise in neighboring cells, thus generating a 
multicellular Ca2+ wave.  Activation of metabotropic receptors (e.g., purinergic 
receptors) in the astrocyte plasma membrane causes a G protein-dependent activation of 
phospholipase C, which leads to the generation of IP3.  This in turn triggers Ca2+ release 
from the ER, which underlies propagating intracellular and intercellular waves (Volterra 
et al., 2002b).  Inhibition of ER Ca2+ accumulation with thapsigargin, which blocks 
SERCA pumps (sarcoplasmic endoplasmic reticulum Ca2+-ATPase) that fill the ER with 
Ca2+, blocks both types of calcium waves.  Additionally, the blockade of IP3 receptors by 
heparin blocks both types of waves as well (Kirischuk et al., 1995; Newman and Zahs, 
1997).  Additionally, blockade of IP3 receptors by 2-aminoethoxydiphenylborate 
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Figure 1.  Model for astrocytic communication.  Hypothalamic astrocytes, like 
those of many brain regions, communicate intercellularly via gap junctions and 
gliotransmitter release.  Diencephalic structures, including the hypothalamus, 
express numerous types of G-protein-coupled melatonin receptors (Brooks and 
Cassone, 1992; Cassone et al., 1995; Reppert et al., 1995; Reppert et al., 1996; 
von Gall et al., 2002; Weaver et al., 1989) and melatonin reportedly modulates 
both gap junctional communication as well as gliotransmitter signaling among 
astrocytes, as seen in avian (diurnal) brains (Peters et al., 2005a).  However, how 
melatonin modulates astrocytic communication among astrocytes derived from a 
rat (nocturnal) brain remains unclear.  A, An increase in inositol (1,4,5)-
trisphosphate (IP3) can trigger a release of Ca2+ from intracellular stores, and IP3 
and Ca2+ can spread to neighboring electrically coupled cells through gap 
junctions formed by connexin proteins.  B, Gliotransmitters, such as ATP and 
glutamate, are also released from glial cells, which bind to receptors on 
neighboring cells and activate signal transduction pathways leading to a rise in 
intracellular calcium in the neighboring cells.  Calcium wave propagation is 
believed to involve both types of astrocytic communication (Nedergaard et al., 
2003).   
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(2-APB) dramatically reduces the propagation of Ca2+ waves among chick diencephalic 
astrocytes (Peters et al., 2005a).  Given that Ca2+ elevations in astrocytes lead to the 
release of these gliotransmitters that, in turn, modulate synaptic transmission among 
neighboring neurons (Araque et al., 1998a; Araque et al., 1998b; Araque et al., 1999b; 
Kang et al., 1998; Robitaille, 1998), the idea of the tripartite synapse (Araque et al., 
1999a) has been proposed.  This idea posits that a synapse should be thought of as 
having three critical elements, the presynaptic terminal and postsynaptic dendritic spine, 
and the astrocytic endfoot that encircles them.  At this tripartite synapse, the associated 
astrocyte listens in to neuronal signaling with appropriate receptors and responds by 
modulating cell signaling at that synapse, that of other synapses in the surrounding area, 
or gliotransmission of neighboring astrocytes (Haydon, 2001). 
 
Melatonin modulation of astrocytes 
Melatonin (5-methoxy-N-acetyltryptamine) is a hormone that is involved in the 
regulation of circadian rhythms in mammals, reptiles, and birds (reviewed in Cassone, 
1990).  Melatonin modulates a variety of physiological functions including sleep, visual, 
cerebrovascular, reproductive, neuroendocrine, and neuroimmunological processes 
(Arendt, 2000; Brzezinski, 1997).  Melatonin levels are dynamically regulated by the 
rhythmic synthesis and rapid degradation (e.g., half-life of melatonin in mammalian 
plasma is about 10 minutes) of melatonin (von Gall et al., 2002).  It is synthesized 
primarily in the pineal gland from serotonin by the sequential actions of the enzymes 
serotonin N-acetyltransferase and 5-hydroxy-indole-O-methyltransferase (Underwood 
and Goldman, 1987).  In mammals, melatonin is removed from the circulation in two 
steps: 1) 6-hydroxylation in the liver and 2) excretion in a sulfatoxy-conjugated form.  
The duration of nocturnal melatonin secretion changes in proportion to the length of the 
night.  Hence, seasonal variations in the length of the solar day are encoded in this 
humoral signal (von Gall et al., 2002).  For example, melatonin production is high 
during the hours of darkness in animals maintained on a light/dark cycle and persists to 
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be highest during the subjective night in animals maintained in constant darkness (Klein 
and Moore, 1979; Moore, 1996; Underwood and Goldman, 1987).   
Melatonin is believed to entrain and synchronize circadian rhythms by activating 
melatonin receptors in the SCN (Dubocovich et al., 1996).  In fact, melatonin production 
is dependent on circadian oscillators within the SCN.  The daily administration of 
melatonin is thought to entrain the underlying rhythmicity of the circadian clock within 
the SCN through daily phase advances.  The cellular mechanisms of circadian clock 
function can be studied by examining the sites and mechansims of melatonin action 
(Cassone, 1990).  Studies examining melatonin’s action on SCN physiology indicate that 
melatonin directly affects the SCN.  For example, in vivo, subcutaneous injection of 
melatonin altered rhythms of 2-deoxy[14C] glucose (2-DG) uptake in a phase- and dose-
dependent fashion in the rat SCN (Cassone et al., 1988). 
Functional Mel1A and Mel1C melatonin receptors have been found in astrocyte-
rich chick diencephalic astrocyte cultures.  In these glial cells, rhythmic administration 
of physiological levels of melatonin imposed a rhythm in 2-DG uptake and the rhythmic 
release of both lactate and pyruvate into the medium (Adachi et al., 2002).  In similar 
primary cultures of chick astrocytes, 10 nM melatonin decreases gap junctional coupling 
and enhances the spread of calcium waves (Peters et al., 2005a).  Similar enhancement 
of calcium waves was seen in mouse hypothalamic astrocytes (Peters et al., 2005b). 
Does melatonin have the same effect in rat suprachiasmatic nucleus cells?  I hypothesize 
that melatonin modulates both gap junctional communication as well as calcium 
signaling among SCN cells (Fig. 1). 
Diencephalic structures, including the hypothalamus, express numerous types of 
G-protein-coupled melatonin receptors (Brooks and Cassone, 1992; Cassone et al., 1995; 
Reppert et al., 1995; Reppert et al., 1996; von Gall et al., 2002; Weaver et al., 1989).  
Western blot analysis has demonstrated that MT1 and MT2 melatonin receptor proteins 
are expressed in both rat SCN tissue in vivo and rat SCN2.2 cells in culture.  Melatonin 
feedback to the master clock, the hypothalamic SCN, acts to inhibit neuronal firing rates 
through activation of the MT1 melatonin receptor (Gillette and McArthur, 1996; Gillette 
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and Mitchell, 2002; Liu et al., 1997).  Activation of the MT2 melatonin receptor is 
responsible for phase shifts in circadian rhythms (Dubocovich et al., 1998; Hunt et al., 
2001).  Since SCN2.2 cells express multiple functional melatonin receptors, these 
cultures have provided a valuable in vitro model for the study of melatonin signaling 
pathway(s) and cellular mechanism(s) by which melatonin regulates circadian activity 
(Rivera-Bermúdez et al., 2004). 
 
ATP signaling 
Intercellular communication between astrocytes and neurons is regulated, in part, by 
ATP signaling (Fellin et al, 2006).  ATP released from astrocytes accumulates as 
extracellular adenosine and regulates synaptic transmission and neural integration 
(Pascual et al., 2005).  However, a pivotal finding was the discovery that communication 
between astrocytes was mediated by ATP as well (Cotrina et al., 1998; Guthrie et al., 
1999).  ATP is thought to be released from astrocytes by multiple mechanisms, which 
may include vesicular exocytosis and release via gap junction hemichannels (Fields and 
Burnstock, 2006).  Recent studies in our group have determined that ATP is accumulated 
in SCN2.2 cell cultures in a rhythmic and circadian fashion with peaks in extracellular 
ATP levels occurring about every 22-24 hours (Womac et al., 2006).  Consequently, 
ATP may represent a circadian output signal of the mammalian SCN.  Since ATP plays 
a critical role in the regulation of astrocytic calcium waves, I hypothesize that the 
circadian accumulation of ATP can influence the spread of calcium waves in 
immortalized SCN cells.  Furthermore, additional studies in our lab have demonstrated 
that the spread of calcium waves in SCN2.2 cell cultures is mediated by a purinergic, 
ATP-dependent signaling pathway.  The addition of apyrase, an ATP 
diphosphohydrolase, to forskolin-treated SCN2.2 cells completely abolishes calcium 
wave propagation (Burkeen and Zoran, 2006).   
In the following chapters, I will present data that the circadian accumulation of 
ATP modulates intercellular communication among SCN cells.  Interestingly, a 
melatonin-mediated phase shift of circadian rhythms occurs at two windows of 
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sensitivity that correspond to the hours around the day-night (dusk) and night-day 
(dawn) transition, and may be related to activation of PKC-dependent pathways (Hunt et 
al., 2001; McArthur et al., 1997).  Hence, I have investigated the potential relationship 
between the circadian release of ATP from SCN cells and melatonin-mediated regulation 
of SCN cell signaling.  I hypothesize that extracellular ATP modulates SCN 
physiological responses to melatonin in SCN cells. 
 The present study utilizes SCN2.2 cells to establish an in vitro model system to 
study intercellular communication among SCN cells, particularly astrocytes.  I have used 
this system to investigate the relationship between melatonin signaling and ATP 
signaling in SCN2.2 cells.  First, I hypothesized that melatonin modulates both gap 
junctional communication as well as calcium signaling among SCN2.2 cells.  To test this 
hypothesis, dye coupling studies and calcium wave studies were conducted to assess 
intercellular communication among SCN2.2 cells.  Second, I theorized that extracellular 
ATP influences the spread of calcium waves in SCN2.2 cells.  Third, I hypothesized that 
extracellular ATP modulates SCN physiological responses to melatonin in SCN2.2 cells.  
As a test, the influence of melatonin on calcium waves was studied in the presence of 
endogenously accumulated or exogenously supplemented ATP. 
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CHAPTER II 
MATERIALS AND METHODS 
 
Cell culture 
Cultures of SCN2.2 cells were grown on laminin-coated culture dishes (60 mm; 
Corning, Corning NY) and maintained at 37ºC and 5% CO2 in Minimum Essential 
Medium (MEM; Invitrogen, Carlsbad, CA), supplemented with 10% FBS, glucose (3000 
µg/ml), L-glutamine (292 µg/ml) and 1% PSN antibiotic (penicillin, streptomycin, 
neomycin; Gibco/Invitrogen, Grand Island, NY).  During cell propagation, the medium 
was changed at 48 hr intervals, and the cultures were split every 2 days.  For all 
experiments, SCN2.2 cells derived from a single passage were propagated as described 
above and then seeded onto cover-glass chambers (Lab-Tek) and allowed to grow to 
confluence (2 days). 
 
Scrape loading dye transfer 
For studies of intercellular dye coupling, confluent SCN2.2 cells were washed with 
calcium/magnesium free media (CMF; Invitrogen, Carlsbad, CA) and then subjected to 
medium replacement with supplemented MEM described above.  Cells were subjected to 
a 30-min. incubation period with melatonin (10 nM; Sigma, St. Louis, MO) and/or 100 
µM carbenoxolone (CBX; Sigma) at 37ºC and 5% CO2.  Carbenoxolone is a gap 
junctional blocker.  Cells were washed with 1X Dulbecco’s phosphate buffered saline 
(PBS; Invitrogen) and exposed to a dye solution containing lucifer yellow (0.05%; 
Sigma) and rhodamine dextran (10,000 Da; 0.0125 mM; Molecular Probes, Eugene, OR) 
dissolved in PBS.  Lucifer yellow is a highly fluorescent dye that allows visualization of 
dye coupling, or gap junctional communication.  Rhodamine dextran is a high molecular 
weight marker dye that is unable to cross gap junctions when introduced intracellularly.  
The dye solution was supplemented with melatonin or CBX as appropriate.  Confluent 
cells on glass-bottom dishes were then damaged with a fresh, sterile scalpel blade or a 
pulled glass pipette tip.  The scrape loading procedure involved dragging each tip gently 
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across the surface of the cells.  As a result of the damage, cells along the edge of the 
scrape became loaded with lucifer yellow and the dye was transmitted to neighboring 
cells coupled via gap junctions.  Cells were washed with PBS and placed in fresh MEM 
(without phenol red) medium with supplements (as described above).  The MEM was 
also supplemented with melatonin or CBX as appropriate.  Imaging was conducted at 
37ºC with an Olympus IX70 inverted microscope connected to an Orca ER CCD camera 
(Hamamatsu).  The 20× objective of the microscope and the camera were used to capture 
a field of cells loaded with lucifer yellow.  Grey level intensity measurements were taken 
using Simple PCI 4.0 imaging software (Compix, Cranberry Township, PA) and dye 
coupling coefficients (ratios) were calculated by dividing each of the cells involved in a 
line of dye spread by the intensity of the first cell that took up the dye minus the 
background.   
 
Ratiometric calcium imaging 
Confluent SCN2.2 cultures were seeded onto cover-glass chambers (Lab-Tek) and 
allowed to grow to confluence (2 days).  Cells were washed with CMF and placed in 
fresh MEM medium with supplements (as described above).  Cells were loaded with 8 
µM Fura-2 AM (diluted from a 1 mM Fura-2 AM stock in a 20% Pluronic F-127 in 
DMSO; Molecular Probes) in culture medium for 1 hr at 37ºC and 5% CO2.  In 
experiments using melatonin, CBX, or luzindole (Luz; Sigma), cells were treated for 1 h 
at 37ºC and 5% CO2 prior to imaging.  Luzindole is a melatonin receptor antagonist.  In 
experiments using ATP (10 nM; Molecular Probes), cells were bathed in ATP for 2 hr 
prior to imaging.  Treatments were added during or after Fura loading as needed.  After 
Fura loading, cells were immediately washed with CMF and fresh culture medium 
(without phenol red) was added to the cells.  Ratiometric calcium imaging was 
conducted at 37ºC with an Olympus IX70 inverted microscope connected to an Orca ER 
CCD camera (Hamamatsu).  The 40× objective of the microscope and the camera were 
used to capture a field, and this full field of cells was considered a region of interest 
(ROI).  Resting calcium levels were first obtained from an ROI, and then a single cell 
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was stimulated once using gentle mechanical stimulation with a micromanipulated glass 
micropipette to elicit an immediate calcium wave.  The area of maximum wave spread 
was calculated (Simple PCI 4.0) for each ROI.  The estimated calcium concentrations 
were calculated using conventional methods (Grynkiewicz et al., 1985).  Images were 
collected for approximately 30-40 s, sufficient time to detect any calcium changes in 
cells within the ROI.  Based on previous experiments, we were confident that a sampling 
time of 30-40 s was sufficient to detect all cells within the ROI involved in a calcium 
wave as calcium levels returned to resting values after this time.  Since a 40× objective 
was used in these experiments, the calculations of maximum wave areas are undoubtedly 
underestimates of the extent of the wave, since they often propagated beyond the field of 
view (Fig. 3D).         
 
SFCF protocol for calcium wave studies 
In calcium wave experiments using the SFCF (serum reduction and forskolin-activation 
with calcium-free media washes) protocol, an entraining stimulus was used to coordinate 
individual cellular oscillations into ensemble rhythms allowing neurons and glial cells to 
become synchronized in vitro.  Confluent SCN2.2 cultures were seeded onto cover-glass 
chambers in culture medium with a decreased FBS concentration of 5% and allowed to 
grow at 37ºC for 24 hr to reach 50% confluence.  After 24 hr, cells were washed with 
CMF and subjected to medium replacement with serum-free Neurobasal medium 
(supplemented with glucose, L-glutamine, and 1X B-27 serum-free supplement; 
Invitrogen, Carlsbad, CA).  Forskolin (15µM; FSK; Calbiochem, La Jolla, CA) was 
added to serum-free medium and cells were incubated at 37ºC and 5% CO2 for 2 hr.  
FSK, an adenylate cyclase agonist that coordinates rhythms by raising concentrations of 
cyclic AMP after activating adenylate cyclase, has been used in previous studies of 
rhythmic clock gene expression and glucose uptake in SCN2.2 cell cultures (Allen et al., 
2001).  Immediately following treatment (time 0), cells were rinsed with CMF and 
maintained thereafter in serum-free Neurobasal medium (2 ml).  Cells were loaded with 
Fura-2 AM as previously described and calcium waves were imaged (as described 
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above) at targeted time points, which were 20 hr and 32 hr from the end of FSK 
treatment.    
 
SR protocol for calcium wave studies  
In experiments using the SR (serum reduction) protocol, confluent SCN2.2 cultures were 
seeded onto cover-glass chambers in culture medium with a decreased FBS 
concentration of 5% and allowed to grow at 37ºC for exactly 24 hr to reach 50% 
confluence.  The plating event served as time 0.  After 24 hr, cells were washed with 
serum-free Neurobasal medium (with supplements as described above) and fresh 
neurobasal medium was added to each well (2 ml).  Note that all subsequent washes 
were performed with serum-free Neurobasal medium instead of CMF.  Cells were 
loaded with Fura-2 AM as previously described and calcium waves were imaged (as 
described above) at targeted time points, which were 40 hr and 50 hr from the plating 
event.    
  
Chemiluminescence assay for analysis of ATP accumulation in culture medium 
For analysis of ATP accumulation in the culture medium, media samples were taken 
prior to calcium wave imaging.  Samples were frozen and stored at -20°C and later 
analyzed for ATP accumulation using a chemiluminescence assay.  The 
chemiluminescence assay of extracellular ATP accumulation was performed by 
aliquoting 100 µl of each media sample, 1 µl of luciferase (3 mg/ml) and 2 µl of 
luciferin (3 mg/ml) per well in a black, 96-well plate (Thermo, Milford, MA).  
Chemiluminescent activity associated with ATP accumulation in the medium was 
measured in constant darkness using a multiplate Packard TopCount scintillation counter 
(Meriden, CT).   
 
2-Deoxyglucose uptake 
For studies of glucose uptake, SCN2.2 cells were subjected to the SR protocol described 
above.  However, instead of Fura-2 AM loading, cells were bathed for 1 hr in serum-free 
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Neurobasal medium (with supplements as described above) containing 2-NBDG (0.1 
mM; Invitrogen), a fluorescent glucose analog that allows glucose uptake to be 
monitored in live cells.  The 2-NBDG incubation was started 30 minutes prior to the 
targeted time point.  During incubations, cultures were paired with 1 well washed and 
exposed to culture medium supplemented with normal glucose (3000 µg/ml) and the 2nd 
well washed and exposed to culture medium containing no glucose.  Immediately 
following 2-NBDG incubations, cells were washed with serum-free Neurobasal medium 
(with supplements) and imaged at 37ºC using an Olympus IX70 inverted microscope.  
Image analysis (Simple PCI 4.0) was performed, where images were analyzed for grey 
level intensity.       
 
Statistics 
In all experiments, multiple ROIs were sampled from multiple independent SCN2.2 
cultures.  The multiple culture wells used in any experiment were derived from the 
passage of a single culture.  Thus, the experimental number (n) throughout every 
calcium wave study equals the total number of ROIs studied across multiple cultures.  
The n for dye coupling studies equals the total number of lines of dye spread, where dye 
can be traced from an initially loaded cell to neighboring, coupled cells to create a 
cellular line of spread made up of 4-5 cells.  Multiple lines of dye spread were found in a 
given ROI, or field of view (Fig. 2B).  Dye-coupling ratios and ratiometric calcium 
imaging data were analyzed using Microsoft Excel and SPSS 13.0 for Windows.  
Treatment groups were statistically compared using one-way ANOVA.  Fisher’s LSD 
post hoc test was used when significant differences were found.  In all cases, p<0.05 
level was used to determine minimum significance.       
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CHAPTER III 
RESULTS 
 
Melatonin modulates gap junctional and gliotransmitter signaling among 
SCN2.2 cells 
Melatonin has been shown to decrease gap junctional communication (using dye 
coupling assays) and enhance gliotransmitter-mediated signaling (using calcium wave 
analyses) in primary cultures of chick diencephalic astrocytes (Peters et al., 2005a).  
Here, I tested the hypothesis that melatonin also modulates both gap junctional coupling 
and gliotransmitter signaling among SCN2.2 cell cultures.  That is, does melatonin have 
the same effects on these nocturnal rodent-derived suprachiasmatic nucleus cells, as it 
did previously on diencephalic cells from a diurnal avian species? 
 
Effects of melatonin on SCN2.2 cell dye coupling 
Melatonin caused a significant decrease in dye coupling at a physiological concentration 
previously shown to have a potent effect in a chicken (10 nM; Peters et al., 2005a).  The 
average dye coupling coefficient (DCC) between SCN2.2 cells, as determined by a 
scrape loading procedure employing the fluorescent dye lucifer yellow (Fig. 2A,B), was 
reduced by 28% compared to control DCC values obtained from vehicle (DMSO)-
treated cultures (Fig. 2C).  Carbenoxolone (100 µM), a gap junction blocker, caused a 
much greater reduction in the average dye coupling of SCN2.2 cells, where the average 
DCC was 95% of that in control cultures.  As in previous studies of chick diencephalic 
astrocytes (Peters et al., 2005a), melatonin decreased dye coupling among SCN2.2 cells. 
Therefore, melatonin appears to have a similar influence (approximately a 30% 
decrease) on dye coupling among SCN astrocytes derived from the SCN of a rat as it did 
on avian diencephalic astrocytes.   
Dye coupling among SCN2.2 cells was not as extensive as that seen previously 
in other avian (Peters et al., 2005a) and mammalian neural cell cultures (Welsh and  
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Figure 2.  Melatonin decreases dye coupling among SCN2.2 cells.  A, A 
representative DIC image of vehicle-treated cells showing a visible line of 
damage produced by the scrape loading procedure.  B, A representative 
image showing the fluorescence of cells containing the dye lucifer yellow.  
The brightest cells along the damage line show the initial uptake of the dye.  
Fainter fluorescence of neighboring cells indicates dye transfer via gap 
junctions.  Note the general lack of dye coupling among the majority of 
cells along the scrape.  C, Melatonin (10 nM) significantly reduced 
(*p<0.05, n=106) the average dye coupling by 28% compared with 
controls (n=30) as determined by calculating a dye coupling coefficient.  
Carbenoxolone (100 µM), a gap junctional blocker, significantly reduced 
(*p<0.05, n=17) dye coupling compared with controls.  Error bars 
represent 95% confidence intervals. 
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Reppert, 1996).  That is, only small clusters of cells along the scrape exhibited dye 
coupling with surrounding cells and many cells were not coupled to neighbors (Fig. 
2A,B).  Additional approaches were used to assess gap junctional communication, such 
as single cell injections with lucifer yellow and fluorescence recovery after 
photobleaching (FRAP).  Both of these approaches confirmed the limited nature of dye 
coupling in these cultures (data not shown).  Therefore, although specific cells in dye 
coupled clusters of SCN2.2 cells had coupling coefficients of approximately 50%, global 
gap junctional communication was low in these cultures.  Nonetheless, melatonin 
significantly reduced this coupling when present.  
 
Effects of melatonin on calcium waves 
Contrary to gap junctional coupling, paracrine communication (i.e., monitored by the 
propagation of intercellular calcium waves) among SCN2.2 cells was robust (Fig. 3A-D). 
Gliotransmitter signaling was examined by mechanical stimulation of calcium waves 
and subsequent measurement of the areas of wave spread.  Following wave activation in 
SCN2.2 cells, the average calcium wave area was not significantly different among 
control and melatonin-treated (10 nM) cultures (Fig. 3E).  On average, melatonin had 
little effect on the magnitude of calcium wave propagation, as it enhanced the spread of 
some waves and reduced the spread of others, often in the same culture well.  This large 
variation in maximal area of wave spread within individual cultures (and consequently 
the large error in the data set; Fig. 3E), indicated that the source of this variation was not 
differences between cell culture passages.  In previous studies of chick diencephalic 
astrocytes (Peters et al., 2005a) and mouse hypothalamic astrocytes (Peters et al., 
2005b), melatonin potentiated intercellular calcium waves.  The lack of significant 
calcium wave modulation by melatonin in rat SCN2.2 cells and the highly variable 
nature of wave propagation may have resulted from a lack of synchrony in these cell 
cultures.  The mammalian SCN is known to be a composite of independent oscillatory 
cells that, when synchronized, exhibit rhythms in gene expression, metabolism, and 
other physiological parameters such as neuronal activity patterns.  Therefore, variation in  
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Figure 3.  Melatonin does not affect the spread of calcium waves among 
SCN2.2 cells.  A-D, Representative calcium wave elicited by mechanical 
stimulation of SCN2.2 cells with a glass micropipette.  Stimulation 
produced an increase in intracellular calcium in the stimulated cell 
followed by subsequent increases in intracellular calcium levels in 
surrounding cells.  The use of a calcium sensitive probe, Fura-2 AM (8 
µM), allowed the spread of the wave to be monitored using ratiometric 
calcium imaging.  The spread of a calcium wave in a vehicle-treated 
(control) culture was monitored over a 20 second time period.  E, The 
average calcium wave area was not significantly different among control 
(n=12) and melatonin-treated (10 nM; n=11) cultures.  Carbenoxolone 
(100 µM; n=12), a gap junctional blocker, completely blocked the spread 
of calcium waves.  Error bars represent 95% confidence intervals. 
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calcium wave propagation, a physiological event that likely requires coherent cellular 
activities, will confound analysis unless controlled by experimental culture condition.   
 To test whether gap junctional coupling was a requirement for calcium wave 
propagation, cells were treated as before with the gap junctional blocker, carbenoxolone 
(CBX).  Interestingly, carbenoxolone (100 µM) completely blocked the spread of 
calcium waves in SCN2.2 cultures (Fig 3E).  This data indicates that functional gap 
junctions might be critical for calcium wave generation.  However, carbenoxolone like 
many uncoupling agents can affect changes in multiple membrane channels and 
receptors, as well as gap junctions.  For example, CBX can still exert an effect on 
purinergic signaling pathways even when astrocytic gap junctions are absent (Cx43 
knockout mice) or have been pharmacologically rendered nonfunctional (Rouach et al., 
2003).  Moreover, CBX has been shown to affect neuronal membrane properties (e.g., 
reductions in firing properties and input resistance) in respiratory neurons of the 
preBötzinger complex (Rekling et al., 2000).  Therefore, our CBX results demonstrate 
that functional, membrane-based cell-to-cell signaling is necessary for calcium wave 
propagation in SCN2.2 cells, but whether or not gap junctional coupling is necessary for 
this intercellular signaling, remains unclear. 
 
Melatonin reduced resting calcium levels 
SCN2.2 cells possessed an average resting cytosolic calcium concentration of 48 ± 2.5 
nM under control conditions, as estimated by ratiometric image analysis with the 
calcium indicator Fura-2 AM (Fig. 4).  Melatonin (10 nM) significantly reduced the 
average resting calcium level by 20% compared to control (vehicle-treated) cultures.  
When the cells were treated with carbenoxolone (100 µM), a significant increase (42%) 
in the average resting cytosolic calcium concentration was observed as compared to 
controls.   
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Figure 4.  Melatonin reduced the resting cytosolic calcium concentration in 
SCN2.2 cells.  At physiological concentrations (10 nM), melatonin significantly 
reduced (*p<0.05, n=11) the average resting calcium level by 20% compared 
with the control (n=12) as estimated by ratiometric calcium image analysis with 
the calcium-sensitive indicator Fura-2 AM (8 µM).  Carbenoxolone (100 µM), a 
gap junctional blocker, significantly enhanced (*p<0.05, n=12) the average 
resting calcium level by 42% over the average control concentration (48 ± 2.5 
nM).  Error bars represent 95% confidence intervals.              
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Extracellular adenosine triphosphate (ATP) influences the spread of calcium waves 
The spread of intercellular calcium waves in astrocytes derived from cortical and 
hippocampal astrocytes are mediated by the gliotransmitter ATP.  Likewise, in SCN2.2 
cultures, calcium waves have recently been shown to be mediated by a purinergic, ATP-
dependent signaling pathway (Burkeen and Zoran, 2006).  In addition, extracellular ATP 
is released from SCN2.2 cells in a rhythmic and circadian fashion, with peak 
extracellular levels of ATP accumulation occurring about every 22-24 hours (Womac et 
al., 2006).  I tested the hypothesis that this extracellular ATP influences the spread of 
calcium waves in SCN2.2 cells.  To monitor and quantify the circadian release of ATP in 
SCN2.2 cultures, cells were manipulated and processed in a specific, thoroughly tested, 
and carefully controlled protocol.  This approach involved the use of an entraining 
stimulus (see Materials and Methods) and passage onto glass-bottom dishes to 
coordinate individual cellular oscillations into ensemble rhythms, allowing SCN2.2 cells 
to acquire sustained and reproducible synchronization of ATP accumulation in vitro.  A 
previously reported, and similar protocol, is known to induce synchronization of cellular 
events similar to those seen in the intact mammalian SCN (Allen et al., 2001).   
 
Effects of ATP on calcium waves  
The level of endogenous extracellular ATP, as determined by a luciferin-luciferase 
chemiluminescence assay, was not correlated with calcium wave area (Fig. 5).  Since 
SCN2.2 cultures display peaks in extracellular ATP content with approximate 24h 
rhythmicity, a circadian phase can be established and multiple peaks and troughs can be 
targeted to examine purinergic signaling (i.e., calcium waves) at given times over the 
course of multiple days.  Initial experiments targeted a trough at 20h and a peak at 32h. 
No correlation between the level of extracellular ATP and the area of the calcium wave 
spread was detected (Fig. 6A,C).  Nevertheless, a robust difference in accumulated ATP 
was present between time points.  In these experiments, the entraining stimulus used to 
coordinate individual cellular oscillations consisted of a combination of:  (1) a serum 
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Figure 5.  The level of endogenously accumulated extracellular ATP had no 
correlation to the calcium wave area.  A scatter plot of the maximum area of wave 
spread (Pearson correlation = -0.081, n=120) is shown with the accompanying 
extracellular ATP content found in the well in which the calcium wave was elicited.  
Extracellular ATP levels were determined by luciferin-luciferase chemiluminescence 
assay.                 
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Figure 6.  Endogenous extracellular ATP accumulation and calcium wave propagation are 
rhythmic and inversely correlated.  A, B, Endogenous levels of extracellular ATP at two targeted 
troughs (20h, 40h; shown in white) and two targeted peaks (32h, 50h; shown in grey), as 
determined by luciferin-luciferase chemiluminescence assay, were different, with higher levels at 
32h and 50h time points.  The levels of extracellular ATP were consistently higher at targeted 
peaks.  Each bar displays the level of ATP in a single representative well.  C, D, The average 
area of wave spread across all wells was not significantly different between the 20h and 32h time 
points.  In contrast, the average area of wave spread was reduced significantly (*p<0.05, n=10) 
by 39% at the 50h time point compared to the 40h time point.  The SFCF protocol was used for 
the 20h and 32h time points in A and C, where as the SR protocol was used for the 40h and 50h 
time points in B and D.  Error bars represent 95% confidence intervals.  
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reduction followed by (2) a forskolin-induced activation of cAMP signaling, and 
subsequently media exchanges (cell washes) using (3) a calcium-magnesium free buffer 
(CMF).  Upon final establishment of the cell cultures in neurobasal medium, the SCN2.2 
cells were considered for time series analysis to be at time 0 (T0).  We have defined this 
three-part entraining protocol as the SFCF treatment, for serum reduction and forskolin-
activation and calcium-free medium.  Figure 6 shows the level of endogenous 
extracellular ATP at a targeted time point from a representative culture and the 
corresponding average wave areas for calcium waves stimulated in that well.  The media 
samples from the representative wells shown had similar extracellular ATP values to 
other wells sampled at the same time point in this experiment. 
One caveat of these experiments was the difficulty in targeting troughs and peaks 
of ATP accumulation using the SFCF protocol, which may have been due to cells not 
adhering as well to the glass dishes as they had to the plastic dishes used in our previous 
studies.  Therefore, the stimulation protocol was changed to allow the cells to grow on 
glass for at least 24h in the presence of serum-containing medium, thus providing better 
cell adhesion to the culture dishes.  The new protocol involved plating the cells to glass 
dishes and retaining 5% FBS in the culture medium for the first 24h on glass.  In 
addition, previous experiments demonstrated that exposure to a low Ca2+ medium caused 
an immediate and substantial increase in the level of extracellular ATP in SCN2.2 cells 
(data not shown).  Also, a clear rhythm in extracellular ATP accumulation was evident 
in cultures not treated with FSK (data not shown).  Therefore, the forskolin treatment 
and CMF washes were removed and we termed this treatment, simply, the serum 
reduction or SR protocol.  Thus, the serum reduction was performed exactly 24h after 
the initial plating to glass dishes and this plating event was defined as time 0 (T0).  
Figure 6B and D shows an experiment performed with the SR protocol.  A robust trough 
(40h) and peak (50h) in extracellular ATP was again determined by chemiluminescence 
assay.  However, a significant difference in calcium wave propagation was now obvious 
between the peak and trough time points.  The level of extracellular ATP varied across 
multiple experiments (i.e., cell culture wells) due to the nature of the circadian 
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oscillations in extracellular ATP seen in these SCN2.2 cultures. Our lab has 
demonstrated that ATP rhythms involve sharp peaks in ATP accumulation, lasting often 
for only 2-4h (Womac et al., 2006), thereby making the absolute peak in ATP levels 
difficult to target in single time point experimental protocols.  Note that the level of 
endogenous extracellular ATP in representative wells was higher at both the 40h and 50h 
time points using the SR protocol, as compared to the 20h and 32h time points using the 
SFCF protocol.  Nonetheless, the 32h and 50h (peak) time points had higher levels of 
ATP accumulation than the 20h and 40h (trough) samples.  Thus, the level of 
extracellular ATP accumulation differed in magnitude between the trough and peak time 
points; however, significant differences in wave propagation were only present using the 
SR protocol at the 40h and 50h time points.  Interestingly, the average area of calcium 
wave spread was reduced significantly by 39% at the 50h (peak ATP) time point 
compared to the 40h (trough ATP) time point.  Therefore, although no correlation 
between the endogenous level of extracellular ATP accumulation and calcium wave area 
was found in the original SFCF induction experiments, the SR protocol led to the 
resolution of the difference in both ATP accumulation and calcium wave magnitude 
between time points.  In addition, there was an inverse relationship between the levels of 
endogenous extracellular ATP and area of calcium wave spread.  It remains to be 
determined whether this relationship is causative or merely correlative.    
 
Effects of melatonin are circadian phase dependent 
Previously, melatonin had no effect on calcium wave signaling among SCN2.2 cells 
(Fig. 3E) where rhythmicity and timing of culture treatments were not controlled.  
However, melatonin may have an effect on calcium wave signaling if the SCN2.2 
cultures express a metabolic rhythmicity.  For example, a combination of glucose 
utilization and ATP accumulation may create an underlying metabolic rhythm to 
modulate intercellular communication differentially, depending on the time of day and 
whether or not melatonin is present.  Therefore, I tested the idea that rhythmic metabolic 
processes, particularly rhythmic accumulation of extracellular ATP, regulate 
 28
physiological responses of SCN cells to melatonin.  Melatonin (10 nM) affected the 
spread of calcium waves at an endogenous trough in the extracellular ATP rhythm (Fig. 
7A), but had no effect on calcium wave spread at the peak time point in the ATP rhythm 
(Fig. 7B).  Different concentrations of melatonin were tested at the trough time point 
(40h), where both 10 pM and 10 nM melatonin significantly reduced calcium wave area 
(Fig. 8).  Luzindole (100 nM or 10 µM), a competitive Mel1b melatonin receptor 
antagonist, did not compete away the effect of melatonin on calcium wave spread among 
SCN2.2 cells.   
 
Interactions between ATP and melatonin signaling in SCN2.2 cells 
Applying exogenous extracellular ATP at a physiological concentration (10 nM) reduced 
the average calcium wave area at both the endogenous trough (40h) and peak (50h) in 
the extracellular ATP rhythm (Fig. 7A,B).  Exogenously applied ATP significantly 
reduced the average calcium wave area by 27% at the trough and by 36% at the peak, 
compared to the average control wave area for each time point.  Surprisingly, although 
both melatonin and exogenous ATP independently reduced the spread of calcium waves 
at the trough time point (40h), they did not have an additive effect on calcium wave area 
when combined.  For example, the combination of 10 nM ATP and 10 nM melatonin at 
40h had essentially the same effect (i.e., a 32% reduction) on the spread of calcium 
waves as ATP and melatonin alone (27% and 31% reductions, respectively). 
Interestingly, melatonin blocked the effect of exogenously applied ATP at the 
endogenous peak of ATP accumulation (Fig. 7B).  The combination of 10 nM ATP and 
10 nM melatonin at 50h had no effect, but ATP alone significantly reduced the area of 
wave spread at this time point.  Therefore, a dynamic interaction between melatonin and 
ATP is evident, at least with regard to the spread of calcium waves. 
 
Melatonin affects extracellular ATP accumulation 
The previous experiments demonstrated that melatonin disrupts the effect of exogenous 
ATP to reduce the spread of calcium waves.  This interaction between melatonin and
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Figure 7.  In SCN2.2 cells, melatonin reduced the spread of calcium waves only 
at the 40h trough in extracellular ATP accumulation; while exogenous ATP 
applied to the culture medium reduced calcium wave spread at both the trough 
and peak in the extracellular ATP rhythm.  A, Calcium wave spread at the trough 
(40h) of the endogenous extracellular ATP rhythm.  Melatonin (10 nM) 
significantly reduced (*p<0.05, n=20) the average calcium wave area by 31% 
compared to the average control wave area following vehicle application.  
Exogenously applied ATP (10 nM) significantly reduced (*p<0.05, n=19) the 
average calcium wave area by 27%, compared to control waves.  A combination 
of both 10 nM ATP and 10 nM melatonin also produced a significant reduction 
(*p<0.05, n=20) in wave area.  B, Melatonin (10nM, n=19) had no effect on 
calcium wave spread at the peak (50h) of the endogenous extracellular ATP 
rhythm.  However, exogenously applied ATP (10 nM) significantly reduced 
(*p<0.05, n=20) the calcium wave area by 36%, compared to control waves.  A 
combination of ATP and melatonin at this time point had no effect on calcium 
wave propagation. 
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Figure 8.  Melatonin dose-dependence at endogenous trough in extracellular ATP.  
Both 10 pM and 10 nM melatonin significantly reduced (*p<0.05, n=10) the average 
area of calcium wave spread compared to controls (n=10).  A combination of 
melatonin (10 nM) and luzindole (100 nM or 10 µM), a competitive melatonin 
receptor antagonist, significantly reduced (*p<0.05, n=10) the average area of 
calcium wave spread.  Error bars represent 95% confidence intervals.         
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ATP signaling led me to ask, and test, the following question.  Does melatonin affect the 
levels of extracellular ATP accumulation in SCN2.2 cultures?  Melatonin treatment (10 
nM) caused a 61% reduction in the level of extracellular ATP at the high ATP time point 
(Fig. 9A), the same time point where it disrupted the effects of exogenously applied 
ATP.  The average area of calcium waves elicited in these cultures was enhanced by 
approximately 33% compared to wave areas in melatonin treated cultures at the low 
ATP time point (Fig. 9B).  Therefore, melatonin treatment produced a reduction in the 
level of extracellular ATP and lead to a significant enhancement in the propagation of 
calcium waves in SCN2.2 cell cultures.  In contrast, melatonin treatment had no effect 
on the spread of calcium waves in cultures containing low ATP, where it, in fact, 
increased ATP levels.  Therefore, melatonin can switch polarity in cellular physiological 
responses, at least with regard to the way it modulates calcium signaling in SCN2.2 
cultures, and depending on the state of the endogenous metabolic rhythm, specifically 
cycles of extracelluar ATP accumulation. 
 
ATP and 2-DG uptake 
SCN2.2 cells exhibit circadian rhythmicity in many properties including their 
extracellular ATP content (Womac et al., 2006) and 2-DG uptake (Earnest et al., 1999b).  
Specifically, SCN2.2 cell cultures express a circadian rhythm in 2-deoxyglucose cellular 
uptake and confer this rhythmicity to cocultured fibroblasts.  This metabolic rhythmicity 
likely functions to modulate cellular physiology of the SCN during an appropriate time 
of day and night.  A future goal of our lab is to determine if these two biological rhythms 
are in phase with each other.  In a preliminary study, I determined whether these two 
rhythms (2-DG uptake and ATP accumulation) possess similar phase relationships.  That 
is, is glucose uptake high when the level of endogenous extracellular ATP is high?  To 
answer this question, the rhythm in 2-DG uptake, monitored as intracellular 
accumulation of the fluorescent glucose analog 2-NBDG, in SCN2.2 cells was examined 
at the same trough and peak time points previously demonstrated for the SR protocol.  
Glucose uptake was 11 % higher when endogenous extracellular ATP levels were at 
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Figure 9.  Extracellular ATP affects melatonin-induced changes in wave 
spread.  A, Endogenous levels of extracellular ATP before and after SCN2.2 
cell cultures were treated with a physiolocial concentration of melatonin (10 
nM) or DMSO (control) for 1h.  ATP levels from three representative wells 
are shown, as determined by luciferin-luciferase chemiluminescence assay.  
Melatonin treatment caused a 61% reduction in the level of extracellular ATP 
in the well labeled “High ATP.”  B, Calcium wave areas for waves elicited in 
the three corresponding wells shown above in A.  The average wave area for 
the well labeled “High ATP” was significantly increased (*p<0.05, n=10) by 
approximately 33% compared to the average control (n=10) wave area.  
Melatonin treatment had no effect on the spread of calcium waves in cultures 
containing low ATP.  Error bars represent 95% confidence intervals. 
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their peak at the 50h time point, as compared to the 40h trough in ATP (Fig. 10).  
Therefore, the oscillations in 2-DG uptake and extracellular ATP accumulation appear to 
correspond in SCN2.2 cell cultures.  However, only one protocol was performed that 
consisted of a 30 minute staining (i.e., 2-NBDG treatment) procedure at two time points.  
Therefore, at this time, we have only established a starting point for an effective 
protocol.  In the future, the protocol may be modified to:  1) have a shorter staining 
period to avoid disrupting cellular metabolism, and 2) decrease the non-labeled glucose 
in the medium instead of completely removing the non-labeled glucose from the 
medium.  Nonetheless, the rhythms in glucose uptake and extracellular ATP 
accumulation may indicate the presence of a fundamental metabolic rhythm in SCN2.2 
cultures, which will need to be examined more thoroughly in the future. 
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Figure 10.  2-Deoxyglucose (2DG) uptake in SCN2.2 cells was higher 
during the peak in extracellular ATP accumulation.  A,C, Representative 
DIC images of SCN2.2 cultures at low cell density.  B,D, Representative 
images showing fluorescence intensity of 2-NBDG uptake in SCN2.2 
cells (corresponding to cells in A and C) at 40h and 50h time points.  Bar 
equals 20 µm (applies to all panels).  E, The average 2-NBDG uptake in 
SCN2.2 cells without glucose in the culture medium (- glucose) was 
significantly increased (*p<0.05, n=12), by 11%, at the 50h peak in the 
ATP rhythm compared to the 40h trough (n=12).  The average 2-NBDG 
uptake in SCN2.2 cells with glucose in their medium (+ glucose) was 
significantly greater (*p<0.05, n=12), by 22%, at the 50h peak in ATP 
accumulation compared to the 40h trough (n=12).  Error bars represent 
95% confidence intervals.   
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CHAPTER IV 
CONCLUSIONS 
 
The neurohormone melatonin modulated cell-to-cell signaling, both dye coupling (gap 
junctional communication) and calcium waves (ATP-dependent gliotransmission) in 
SCN2.2 cells, a cell line derived from the rat SCN.  The cellular physiology regulating 
how these cells communicate through gap junctions and ATP-dependent 
gliotransmission and how that communication might be regulated by melatonin will be 
discussed in the context of mammalian biological clock function. 
 
Melatonin regulates gap junctional communication 
Evidence of gap junctional communication in the suprachiasmatic nucleus of rats has 
been well established (Batter et al., 1992; Welsh and Reppert, 1996; Blomstrand et al., 
1999).  In vitro (Batter et al., 1992) and in vivo (Yamamoto et al., 1990a,b) studies 
demonstrate that gap junction expression is different, among astrocytes from one brain 
region and between astrocytes derived from different brain regions.  These brain-region 
specific differences in coupling have been suggested to promote functional 
specialization within the central nervous system.  For instance, approximately 30% of 
hypothalamic astrocytes in the rat brain form functional junctions with their neighbors, 
whereas striatal astrocytes are less extensively coupled (Batter et al., 1992).  Gap 
junctional coupling strengths are ranked as follows: hippocampus = hypothalamus > 
cerebral cortex = brain stem (Blomstrand et al., 1999).  Although gap junctional 
coupling is higher in the hypothalamus compared to other brain regions, surprisingly, 
global gap junctional communication (dye coupling) was low in SCN2.2 cultures (Fig. 
2B).  Multiple approaches were used to assess gap junctional communication, such as 
extensive scrape loading experiments and single cell injections with lucifer yellow, as 
well as FRAP analyses.  Each of these approaches confirmed the limited nature of dye 
coupling in these cultures.  This apparent contradiction may represent an artifactual 
restriction in gap junctional coupling between SCN2.2 cells, perhaps due to 
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consequences of their immortalization or their specific cell culture conditions.  
Alternatively, coupling among astrocytes within the SCN may not be typical of coupling 
seen in the hypothalamus in general.  In fact, quantitative analyses of gap junctional 
coupling among rat SCN astrocytes in vivo have not been conducted.  Still, low levels of 
dye coupling in these SCN2.2 cultures does not abrogate the importance of gap 
junctional communication in the SCN, which may be critical for neuronal cell-cell 
communication in restricted populations of glial cells, and thus for general SCN cellular 
function.  Colwell (2000) has suggested that gap junctions may provide a mechanism to 
functionally couple distinct SCN cell populations.  Individual SCN neurons express 
independently phased circadian rhythms (Welsh and Reppert, 1996) and thus are 
considered single cell circadian oscillators.  Considerable interest in the cellular 
mechanisms underlying coupling of independent oscillators has driven recent research in 
the SCN (Hastings and Herzog, 2004) and clocks fields (Bell-Pedersen et al., 2005). 
Consequently, gap junctions may provide a signaling pathway for individual cells to 
form a linked cellular ensemble and functional timing system in the SCN.   
 Melatonin has been shown to modulate gap junctional connectivity in chick 
diencephalic glial cell cultures (Peters et al., 2005a).  In agreement with these studies, I 
have demonstrated here that nanomolar concentrations of melatonin, a physiological 
level present in the circulatory systems of birds and mammals during the night (Cassone 
and Menaker, 1983; Cassone et al., 1986; Pang and Ralph, 1975), reduced dye coupling 
(gap junctional communication) in SCN2.2 cells.  These data showing melatonin-
mediated reductions in SCN cell dye coupling make sense because:  1) melatonin levels 
are high at night in all animal species previously examined, regardless of whether they 
are diurnally or nocturnally active (Simonneaux and Ribeleyga, 2003), and 2) SCN 
neurons are electrically silent and minimally dye coupled during the night (Colwell, 
2000).  Thus, a causal relationship may exist whereby melatonin levels rise during the 
hours of darkness to reduce gap junctional communication in the SCN and create a 
“nighttime” mode of communication within the mammalian brain.  Thus, the current 
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studies of SCN2.2 astrocytic coupling suggest that nighttime reductions in coupling may 
be a fundamental feature of both SCN neuronal and glial cell circadian physiology. 
 The SCN allows the mammalian body to anticipate and prepare for night- and 
day-specific demands.  The SCN’s ability to communicate in two ways depending on 
whether it is daytime or nighttime may provide functionally different information to 
peripheral targets.  Consider the following scenario in the context of astrocytic 
communication within the rat SCN.  The current data, and that of Peters et al. (2005a), 
suggest that gap junctional coupling is more important to SCN astrocytes during the day.  
Perhaps this is because SCN neurons at this time exhibit high levels of synchronous 
neural activity (Colwell, 2000).  If SCN neurons are synchronized, then it may be 
beneficial for nearby astrocytes, which are supplying these neurons with nutrients and 
buffering transmitter and ionic level in the extracellular fluid, to also be synchronized 
via gap junctional connectivity.  Furthermore, gap junctional communication between 
astrocytes, and between astrocytes and neurons, may contribute to the generation of this 
enhanced synchronous activity in the first place.  The tripartite synapse hypothesis 
suggests that a synaptic astrocyte listens to neuronal signaling with appropriate receptors 
and responds by modulating neurotransmission at that synapse and at those of other 
synapses in the surrounding area (Volterra et al., 2002a).  Thus, melatonin and its 
reduction of astrocytic gap junctional coupling may be dynamically involved in 
determining the coupling state of SCN cells, thereby influencing the physiological state 
of the master biological clock. 
 
Melatonin regulates gliotransmission 
One premise of the tripartite synapse hypothesis is that purinergic signaling between 
synaptic partners, and the astrocytes that surround them, is critical to the modulaton of 
mammalian neural intregration.  Here, I have demonstrated that melatonin also 
influences ATP-dependent gliotransmission in SCN hypothalamic astrocytes.  ATP is 
known to mediate glial calcium waves in astrocytes derived from various brain regions 
such as the cortex (Guthrie et al., 1999) and cerebellum (Kirischuk et al., 1995).  
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Purinergic cell-cell signaling, in the form of calcium waves, occurred in SCN2.2 cells, 
and these calcium waves were ATP-dependent, as the addition of apyrase, an ATP 
diphosphohydrolase, to the cells completely abolished calcium wave propagation 
(Burkeen and Zoran, 2006).  Purinergic signaling is critical to neural function because 
ATP released from astrocytes accumulates as extracellular adenosine, which activates 
receptors in the hypothalamus to regulate sleep behavior in mammals (Scammell et al., 
2001), and regulates synaptic transmission and neural integration in the hippocampus 
(Pascual et al., 2005).  Melatonin, which is high at night, has been shown to modulate 
ATP-mediated gliotransmission in diurnal mammals (Peters et al., 2005a).  I have 
demonstrated here that melatonin affects the nature of ATP-dependent gliotransmission 
in SCN2.2 cells.  Moreover, we predict that melatonin’s effect on astrocytes is an MT1 
mediated modulation since luzindole, primarily an MT2 antagonist (Dubocovich et al., 
1998), did not block the effect of melatonin.  However, more pharmacology will be 
needed to test this idea.  In contrast to the effect seen in a diurnal chicken, melatonin 
suppressed gliotransmission (e.g., calcium waves) in these cells derived from the SCN of 
the nocturnal rat.  Although, the previous studies with diurnal animals (e.g., birds) did 
not incorporate time elements into their studies, brain physiology, especially in the SCN 
of the diencephalon, is quite different during the daytime versus nighttime.  In our 
studies, melatonin effects on gliotransmission were highly variable when timing of 
cultures was not carefully controlled.  On the other hand, a clear and significant 
reduction of calcium waves occurred at specific time points in cycling (as determined by 
rhythms of ATP accumulation) SCN cultures.  If the previous work with diurnal 
mammals holds true even when the cycling of the SCN is controlled for, then melatonin 
may affect the diurnal SCN of an animal with higher energy expenditure during the day 
differently than it affects the nocturnal SCN of an animal with higher energy expenditure 
at night.  This differential modulation by melatonin may be necessary to properly 
regulate an animal’s physiology, since melatonin levels peak at night in both diurnal and 
nocturnal animals. 
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Melatonin influences the relationship between gap junctional communication and 
gliotransmitter signaling 
Adding to the complexity of melatonin’s role in SCN physiology, melatonin appears to 
not only modulate gap junctional communication and gliotransmitter signaling 
separately, but it also has a dynamic effect on the relationship between gap junctional 
and chemical communication.  For example, melatonin imposes a functional switch in 
the nature of intercellular communication among chick diencephalic astrocytes.  
Melatonin reduces Cx43 expression, yet enhances intercellular Ca2+ wave propagation 
(Peters et al., 2005a).  Thus, ATP-mediated gliotransmission, in this study of chick 
astrocytes, was greater when gap junctional coupling was low.  This data supports the 
idea of a “nighttime” versus “daytime” neural integration system within the 
hypothalamus.  This data also raises a question as to whether or not gap junctions are 
needed for the spread of waves.  For example, perhaps gap junctions are not as important 
to intercellular communication at night since melatonin acts to reduce gap junctional 
coupling.   
 I demonstrated that CBX, a gap junctional blocker, virtually abolished both dye 
coupling and Ca2+ wave propagation, while increasing resting intracellular calcium 
levels in SCN2.2 cultures.  This increase in intracellular resting calcium may provide a 
clue into the mechanism of calcium wave suppression.  At high doses of melatonin 
(µM), which caused a significant elevation in resting calcium levels in chick astrocytes, 
calcium waves were also abolished (M. Zoran, personal communication).  Yet, caution 
must be used when interpreting the effects of CBX because this chemical does not exert 
its effect by working directly on gap junctions.  Carbenoxolone works through some 
other unknown mechanism that may alter membrane physiology and many membrane-
associated proteins.  For example, CBX disrupts astrocytic gap junctional 
communication, yet can still exert its effect when astrocytic gap junctions are absent 
(Cx43 knockout mice) or nonfunctional (Rouach et al., 2003).  In the future, 
development of pharmacological agents that target gap junctions more directly will be 
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useful in uncovering the underlying mechanisms involved in the daily rhythms of gap 
junctional and chemical communication in the SCN.  
 
Extracellular ATP accumulation regulates gliotransmission 
The present studies indicated that another important component of gliotransmitter 
signaling (calcium wave propagation) is the daily rhythm in the accumulation of 
extracellular ATP in the SCN.  However, a discussion of extracellular ATP 
accumulation must be preceded by an understanding of the cell culture protocol that 
must be employed to synchronize cycling cell cultures, a procedure that reveals the 
rhythm in ATP accumulation in the first place.  Since individual SCN cells act as single 
cell circadian oscillators (Hastings and Herzog, 2004), cell culture manipulations are 
needed to coordinate individual cellular oscillations into ensemble rhythms.  Our lab 
developed a protocol known as the SR protocol to monitor and quantify the circadian 
release of ATP in SCN2.2 cultures.  Cells were manipulated and processed in a specific, 
thoroughly tested, and carefully controlled protocol (see Material and Methods).  This 
approach involved the use of an entraining stimulus to coordinate individual cellular 
oscillations allowing SCN2.2 cells to acquire sustained and reproducible synchronization 
of ATP accumulation in vitro.  Most notably, the timing of media exchanges must be 
precise (e.g., exactly 24h) and exposure to low Ca2+ medium must be avoided to 
circumvent randomness of ATP accumulation in cultures.  Consequently, I found that 
extracellular ATP accumulation is correlated with significant rhythms in 
gliotransmission (calcium waves) in SCN2.2 cells and that this relationship may be more 
than correlative.  When endogenous levels of extracellular ATP were higher (50 hour 
time point), calcium waves were smaller (Fig. 6).  Yet, exogenously applied ATP (i.e., 
higher ATP levels) reduced the spread of calcium waves at both the endogenous trough 
(40 hour time point) and peak (50 hour time point) in extracellular ATP accumulation.  
Therefore, exogenous ATP reduced the spread of calcium waves regardless of the time 
of application during the endogenous 24 hour ATP accumulation cycle.   
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 How might ATP be regulating calcium waves?  The current and conventional 
wisdom suggests that vesicular release of ATP mediates calcium-dependent purinergic 
signaling among astrocytes (Pangrsic et al., 2007).  In this model of ATP-dependent 
gliotransmission, released and extracellularly accumulated ATP binds to P2Y receptors 
on neighboring cells.  This P2Y receptor activation leads to activation of an IP3–
dependent signaling mechanism and the elevation of resting calcium levels via release 
from intracellular stores (Charles, 2005).  Elevation of calcium levels elicits a calcium-
dependent release of ATP, which in turn evokes Ca2+ responses in nearby astrocytes. 
Thus, the astrocytic calcium wave is propagated.  My results suggest another component 
is involved in this pathway - an underlying rhythm in purinergic responsiveness.  That is, 
clock outputs may be determining a state of responsiveness to ATP.  I have 
demonstrated here that ATP and calcium waves are both rhythmic and inversely 
correlated in cycling SCN2.2 cultures (Fig. 11).  Although a direct regulation of 
purinergic receptor gene expression by the clock is possible, or even likely since many 
ATP- and metabolism-associated genes are know to be rhythmic in both the rat SCN and 
in SCN2.2 cultures (Menger et al., 2005; Menger et al., 2007), a equally plausible 
explanation is that accumulating levels of extracellular ATP lead to the desensitization 
of purinergic receptors.  This would create a state of reduced purinergic responsiveness 
at the peak of the ATP accumulation rhythm, when ATP-dependent calcium waves are 
reduced in magnitude.  Further studies will be required to differentiate among multiple 
explanations for these results. 
 The role that ATP accumulation plays in SCN function remains unknown.  
However, in the central nervous system, work has demonstrated that ATP in 
extracellular fluids modulates neuronal activities including neurotransmission, 
endocrine/exocrine secretion, immune reactions, and inflammatory reactions (Dubyak 
and el-Moatassim, 1993; Bruns, 1990).  Clock controlled release of ATP from astrocytes 
may feedback to cellular components of the SCN to further modulate the cellular release 
of ATP, or alter the state of the SCN cells’ responsiveness to ATP. 
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Figure 11.  Proposed temporal relationship between melatonin signaling and ATP 
signaling in the rat SCN to produce precisely timed shifts in intercellular 
communication among SCN cells.  The endogenous rhythms in melatonin 
production from the pineal gland and extracellular ATP accumulation within the 
SCN may combine to create windows of sensitivity (grey lines) when intercellular 
communication (e.g., calcium waves propagation and gap junctional 
communication) within the SCN can be functionally shifted to accommodate 
daytime versus nighttime physiological needs.  For example, in the hours prior to 
their daily nocturnal (Night, horizontal black bar) activity, rats experience clock-
controlled changes in their body chemistry to prepare them for this upcoming 
active time period.  During this time, glucose utilization (production and uptake) is 
peaking, extracellular ATP accumulation in the SCN is peaking, and melatonin 
levels are on the rise.  We propose that this period of time is critical to shifting the 
way cells in the SCN communicate with each other.  In this example, the SCN cells 
will then shift from a daytime state of cell-cell signaling (Day, horizontal white 
bar) to a nighttime mode of communication, which includes reduced calcium wave 
signaling (gliotransmitter signaling) due to the combined influence of low 
extracellular ATP levels and high circulating melatonin levels. 
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Melatonin and ATP signaling pathways interact to regulate gliotransmission 
The present study demonstrates that melatonin and ATP interacted in the regulation of 
gliotransmission (calcium waves).  Additionally, these interactions were specific to 
endogenous SCN rhythmicity.  For example, melatonin affected the spread of calcium 
waves only at a trough in the endogenous rhythm in extracellular ATP accumulation 
(Fig. 7).  Interestingly, melatonin and ATP did not have an additive effect on the 
modulation of calcium waves, but melatonin blocked the effect of supplemental ATP 
only at the endogenous peak in the rhythm of extracellular ATP accumulation.  Thus, a 
complex interaction exists between melatonin and ATP signaling pathways, with this 
relationship linked to the endogenous cycling of SCN cellular physiology.   
 Interestingly, my data suggest that part of this relationship may not be simply 
correlative, but causative, because melatonin altered ATP accumulation in cycling 
SCN2.2 cultures.  In cultures containing high ATP, melatonin treatment reduced the 
level of extracellular ATP and led to a significant enhancement in the propagation of 
calcium waves.  In contrast, melatonin treatment in cultures containing low ATP caused 
an elevation in those ATP levels.  Therefore, melatonin can alter the amplitude of the 
endogenous rhythm in ATP accumulation and thereby switch the polarity of calcium 
signaling in SCN2.2 cultures.  It remains to be determined if other effects of melatonin 
on SCN cells, like neuronal activities, might also be linked to rhythms of ATP 
accumulation.  Like many circadian rhythms, the rhythms in ATP accumulation within 
the SCN and melatonin production from the pineal gland may come together to create 
unique physiological states at certain times of day.  Fascinatingly, a melatonin-mediated 
phase shift of circadian rhythms occurs at two windows of sensitivity that correspond to 
the hours around the day-night (dusk) and night-day (dawn) transitions (Hunt et al., 
2001).  In rats, the hours just before the day-night transition correspond to the hours just 
prior to their period of highest activity.  Thus, it makes sense that melatonin would be 
able to modulate ATP accumulation precisely as the rhythm in extracellular ATP is 
peaking for a given 24 hr period and as the animal is altering its body chemistry in 
preparation to wake up and become active.  The significance of ATP and melatonin 
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signaling interactions is unclear.  Perhaps these interactions are a result of coordinated 
circadian rhythms that possess a specific phase relationship to modulate intercellular 
communication in the SCN at certain times of day.   
 
Melatonin action, ATP accumulation, and glucose uptake in SCN2.2 cells 
Another circadian rhythm to consider in the context of melatonin and ATP signaling 
interactions is glucose uptake.  SCN2.2 cells are capable of endogenously generating 
circadian rhythms in 2-deoxyglucose (2-DG) uptake (Earnest, et al., 1999b).  The daily 
rhythms in plasma glucose concentration and glucose uptake both follow the same daily 
pattern of rising before the onset of activity (la Fleur, 2003).  Glucose demands change 
during a 24h light/dark cycle and glucose metabolism is modulated by the SCN in a 
rhythmic fashion, independent of the SCN’s strong influence on food intake.  The CNS 
relies on blood glucose as its most important energy source.  In preliminary experiments, 
I have demonstrated here that 2-DG uptake in SCN2.2 cells coincided with peak times of 
ATP accumulation (Fig. 10).  That is, the uptake of 2-NBDG, a fluorescent glucose 
analog, was higher at the 50h peak in the endogenous extracellular ATP rhythm, as 
compared to the 40h trough.  Thus, ATP appears to be accumulated in the extracellular 
medium of SCN2.2 cultures during the same time that these cultures experienced high 
glucose uptake.  Perhaps the accumulation of extracellular ATP is a result of enhanced 
glucose utilization.  
 Many questions are raised by these studies of SCN2.2 cell-cell communication 
and only a few are answered.  One big question that remains is what is the mechanism 
underlying, and the function of, rhythmic ATP accumulation in SCN cultures.  Recent 
studies in our lab suggest that rhythms in ATP accumulation are not specific to neural 
astrocytes, but rather may be common to several cell types (Womac et al., 2006).  Even 
so, the fact that melatonin, purine gliotransmission, gap junctional signaling, and 
calcium signaling all exhibit complex interactions that in one aspect or another are 
linked to the circadian rhythm in ATP accumulation suggests that SCN physiology is 
critically influenced by this rhythmic process.  Several studies have demonstrated a link 
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between ATP activation of P2X receptors and calcium-dependent cellular processes 
(Arcuino et al., 2002; Locovei et al., 2006; Suadicani et al., 2006).  This is interesting 
since regulation of intracellular calcium by membrane channels has been implicated in 
the regulation of SCN circadian rhythmicity (Nahm et al., 2005).  It is likely that an 
intersection of research in astrocyte-neuron signaling, purinergic regulation of cellular 
physiology, and coupling mechanisms in the SCN will be required to fully illuminate the 
broad spectrum of implications and the ultimate significance to biological clock function 
in the research presented here. 
 In summary, clock-controlled ATP release and accumulation in SCN cell cultures 
modulates ATP-dependent gliotransmission in the form of interastrocytic calcium 
waves.  Melatonin signaling and ATP accumulation interact within these SCN cultures 
to influence each other and the processes they regulate in a fashion dependent on the 
clock’s control of the ATP accumulation rhythm.  It will be fundamental to any ultimate 
understanding of how the SCN clock functions to determine the mechanism by which 
these processes modulate intercellular communication within the suprachiasmatic 
nucleus and how that modulation directly affects SCN outputs.  In other words, how do 
rhythms in the regulation of cell-cell communication within the SCN, produce coherent 
daily oscillations that drive rhythms in behaviors and homeostatic functions of 
organismal physiology. 
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APPENDIX 
 
 
Experiment protocols 
 
Figure 2 (scrape loading) 
 
1. Obtain 1-60 mm dish containing confluent SCN2.2 cells. 
2. Expand the dish to 4 glass coverslip bottom dishes (2 chamber wells per dish). 
3. Label the dishes #1 (control), #2 (CBX), #3 (Mel), & #4 (CBX & Mel). 
4. Place cells in 37ºC incubator containing 5% CO2 until the cell cultures reach 
confluence. 
5. Remove cells from incubator and wash twice with CMF (calcium magnesium 
free) solution containing Dulbecco’s PBS (1X) and 0.2% glucose. 
6. Add 1,950 µl SCN media consisting of MEM with 10% FBS, 0.4% glucose, and 
2 mM L-glutamine to each well. 
7. Add 50 µl H20 (cell culture grade) to each well in dish #1 (control). 
Add 50 µl of 4 mM CBX (100 µM CBX final concentration) to each well in dish 
#2.  Next, pipette solutions in and out to mix.  Use new pipette tips for each well. 
8. Incubate dishes #1 & #2 for 30 min. at 37ºC. 
9. While waiting, begin next incubation: 
a. Remove dishes #3 and #4 from incubator. 
b. Wash each well twice with CMF. 
c. Add 2 ml SCN media to each well. 
d. Add 0.2 µl of 0.1 mM Melatonin in DMSO (10 nM Mel final 
concentration) to each well in dish #3.  Pipette solution in and out to mix.  
Note: first remove 0.2 µl of media solution from each well before adding 
melatonin to keep concentrations correct. 
e. Add 50 µl of 4 mM CBX (100 µM CBX final concentration) to each well 
in dish #4.  Pipette to mix. 
Add 0.2 µl of 0.1 mM Melatonin in DMSO (10 nM Mel final 
concentration) to each well in dish #4.  Pipette to mix. 
Note: Before adding CBX or Mel, remove an amount of media from the 
well equal to the amount of treatment solution being added to keep 
concentrations correct. 
f. Incubate dishes #3 & #4 for 30 minutes at 37ºC. 
10. Remove dishes #1 & #2 from incubator.   
Wash each well twice with Dulbecco’s PBS (1X). 
11. Add 1,950 µl of dye solution (0.05% Lucifer yellow/ 0.0125 mM Rhodamine 
dextran in Dulbecco’s PBS) to each well in dishes #1 & #2. 
Add 50 µl H20 (cell culture grade) to each well in dish #1.  Pipette to mix. 
Add 50 µl 4 mM CBX (100 µM CBX final concentration) to each well in dish 
#2.  Pipette to mix. 
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12. Obtain a sterile stainless steel surgical scalpel blade or a pulled glass pipette tip.  
Perform scrapes in all wells of dishes #1 and #2 by dragging tips gently across 
the surface of the cells.  Change tips between dishes.  Next, wash all wells with 
Dulbecco’s PBS (1X) three times to remove background fluorescence. 
13. Add 1,950 µl SCN media (without phenol red) to each well in dishes #1 & #2. 
Add 50 µl H20 (cell culture grade) to each well in dish #1.  Pipette to mix. 
Add 50 µl 4 mM CBX (100 µM CBX final concentration) to each well in dish 
#2.  Pipette to mix. 
14. Image using Olympus IX70 inverted microscope. 
15. Remove dishes #3 & #4 from incubator. 
a. Wash each well twice with Dulbecco’s PBS. 
b. Add 2 ml dye solution (0.05% Lucifer yellow/ 0.0125 mM Rhodamine 
dextran in Dulbecco’s PBS) to each well in dishes #3 & #4. 
c. Remove 0.2 µl of dye solution from each well in dish #3. 
Add 0.2 µl of 0.1 mM Melatonin (10 nM Mel final concentration) to each 
well in dish #3.  Pipette to mix. 
d. Remove 50.2 µl of dye solution from each well in dish #4. 
Add 50 µl of 4 mM CBX (100 µM CBX final concentration) to each well 
in dish #4.  Pipette to mix. 
Add 0.2 µl of 0.1 mM Melatonin (10 nM Mel final concentration) to each 
well in dish #4.  Pipette to mix. 
e. Perform scrapes in all wells of dishes #3 & #4 as in step #12 above. 
f. Wash each well three times with Dulbecco’s PBS (1X). 
g. Add 2 ml SCN media (without phenol red) to each well. 
h. Remove 0.2 µl of the media from each well in dish #3. 
Add 0.2 µl of 0.1 mM Melatonin (10 nM Mel final concentration) to each 
well in dish #3.  Pipette to mix. 
i. Remove 50.2 µl of media from each well in dish #4. 
Add 50 µl of 4 mM CBX (100 µM CBX final concentration) to each well 
in dish #4.  Pipette to mix. 
Add 0.2 µl of 0.1 mM Melatonin to each well in dish #4.  Pipette to mix. 
j. Image using Olympus IX70 inverted microscope. 
 
 
Figures 3 & 4 (calcium waves) 
 
1.   Obtain 1-60 mm dish containing confluent SCN2.2 cells. 
2.   Expand the dish to 4 glass coverslip bottom dishes (2 chamber wells per dish). 
3. Label the dishes #1 (control), #2 (CBX), #3 (Mel), & #4 (CBX & Mel). 
4. Place cells in 37ºC incubator containing 5% CO2 until the cell cultures reach 
confluence. 
5. Remove all wells from incubator.  Wash each well twice with CMF.  Add 2 ml 
fresh SCN media to each well.  Place wells back in incubator. 
6. Prepare Fura-2 AM (calcium indicator) solution: 
 57
• Add 15 ml SCN media to one epitube. 
• Add 120 µl of 1 mM Fura-2 AM in Pluronic F-127 *20% solution in 
DMSO to same epitube. 
• Vortex and cover in foil to protect from light. 
• Final concentration of calcium indicator solution equals 8 µM Fura-2 
AM. 
7. Remove dish #1 (control) from incubator.  Discard media. 
Add 1.5 ml of calcium indicator solution to each well. 
Incubate for 1 hour at 37ºC. 
Wash each well three times with CMF. 
Add 1.5 ml SCN media (without phenol red) to each well. 
Image calcium waves using Olympus IX70 inverted microscope. 
8. Remove dish #2 (CBX) from incubator.  Discard media. 
Add 1.5 ml calcium indicator solution to each well. 
Remove 37.5 µl of this solution from each well and discard. 
Add 37.5 µl of 4 mM CBX (100 µM CBX final concentration) to each well.  
Pipette to mix.  Next, incubate the dish for 1 hour at 37ºC. 
Wash each well three times with CMF. 
Add 1.5 ml SCN media (without phenol red) to each well. 
Remove 37.5 µl of media from each well and discard. 
Add 37.5 µl of 4 mM CBX (100 µM CBX final concentration) to each well.  
Pipette to mix. 
Image calcium waves using Olympus IX70 inverted microscope. 
9. Remove dish #3 (Mel) from incubator.  Discard media. 
Add 1.5 ml calcium indicator solution to each well. 
Remove 0.15 µl of this solution from each well and discard. 
Add 0.15 µl of 0.1 mM Melatonin in DMSO (10 nM Mel final concentration) to 
each well.  Pipette to mix. 
Incubate the dish for 1 hour at 37ºC. 
Wash each well three times with CMF. 
Add 1.5 ml SCN media (without phenol red) to each well. 
Remove 0.15 µl of the media from each well and discard. 
Add 0.15µl of 0.1 mM Melatonin in DMSO (10 nM Mel final concentration) to 
each well.  Pipette to mix. 
Image calcium waves using Olympus IX70 inverted microscope. 
10. Remove dish #4 (CBX & Mel) from incubator.  Discard media. 
Add 1.5 ml calcium indicator solution to each well. 
Remove 37.65 µl of this solution from each well and discard. 
Add 37.5 µl of 4 mM CBX (100 µM CBX final concentration) to each well.  
Pipette to mix. 
Add 0.15 µl of 0.1 mM Melatonin in DMSO (10 nM Mel final concentration) to 
each well.  Pipette to mix. 
Incubate the dish for 1 hour at 37ºC. 
Wash each well three times with CMF. 
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Add 1.5 ml SCN media (without phenol red) to each well. 
Remove 37.65 µl of media from each well and discard. 
Add 37.5 µl of 4 mM CBX (100 µM CBX final concentration) to each well.  
Pipette to mix. 
Add 0.15 µl of 0.1 mM Melatonin in DMSO (10 nM Mel final concentration) to 
each well.  Pipette to mix. 
Image calcium waves using Olympus IX70 inverted microscope. 
 
 
Figure 5 (calcium waves – SFCF protocol) 
  
Note: This protocol contains time points to target low and high levels of 
endogenously accumulated extracellular ATP. 
1.   Obtain 1-60 mm dish containing confluent SCN2.2 cells. 
2.   Expand the dish to 4 glass coverslip bottom dishes (2 chamber wells per dish). 
During expansion, suspend the pellet of cells in SCN media containing 5% FBS 
(instead of the usual 10% FBS).  The SCN media added to each well should also 
contain 5% FBS.   
*Note that this step serves as the first serum reduction event. 
Place the cells in 37ºC incubator containing 5% CO2 until the cell cultures reach 
50% confluence.  This takes 24 hours. 
3. After 24 hours, remove all wells from incubator.   
Wash each well twice with CMF. 
Add 2 ml neurobasal media (contains neurobasal medium along with B-27 
supplement, L-glutamine, and glucose) to each well. 
*Note that this step serves as the final serum reduction event. 
Label the wells #1 - #8 and place back in 37ºC incubator. 
4. At 34 hours prior to imaging, remove wells #1 - #4 from incubator. 
Add 2 µl of 15 mM forskolin in 100% DMSO (final concentration of 15 µM FSK 
in 0.1% DMSO) to each well.  Pipette to mix. 
Note: first remove 2 µl of media from well and discard before adding the FSK. 
Incubate wells #1 - #4 at 37ºC for 2 hours. 
This serves as the FSK pulse for the 32 hour time point.  
5. After 2 hours, remove wells #1 - #4 from incubator and wash each well twice 
with CMF.  Add 2 ml neurobasal media to each well.  Place wells in 37ºC 
incubator. This step serves as time 0 for the 32 hour time point. 
6. At 22 hours prior to imaging, remove wells #5 - #8 from incubator. 
Wash each well twice with CMF and add 2 ml neurobasal media to each well. 
Add 2 µl of 15 mM FSK in 100% DMSO (final concentration of 15 µM FSK in 
0.1% DMSO) to each well.  Remember to first remove 2 µl of media and discard 
before adding the FSK to each well.  Pipette to mix. 
Incubate wells #5 - #8 at 37ºC for 2 hours. 
This serves as the FSK pulse for the 20 hour time point. 
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7. After 2 hours, remove wells #5 - #8 from incubator and wash each well twice 
with CMF.  Add 2 ml neurobasal media to each well.  Place wells in 37ºC 
incubator. This step serves as time 0 for the 20 hour time point. 
8. Note that the 32 hour and 20 hour time points are created by counting backwards 
from the actual time that calcium waves are imaged.  This allows calcium wave 
imaging to be performed simultaneously for both time points. 
9. At 2 hours prior to imaging, begin Fura-2 AM incubations.  See protocol for Fig. 
3 & 4 step #6 for calcium indicator solution preparation. 
10. Remove wells #1 & #2 from incubator and wash each well twice with CMF.  
Add 1.5 ml Fura-2 AM calcium indicator solution to each well.  Incubate wells at 
37ºC for 1 hour. 
11. Remove wells #1 & #2 from incubator.  Wash each well three times with 
neurobasal media.  Add 2 ml neurobasal media to each well.  
12. Place wells #1 & #2 in 37ºC for 1 hour for recovery period. 
13. After 1 hour, collect a 1 ml media sample from each well and place in -20ºC 
freezer.   
14. Image calcium waves for wells #1 & #2 using an Olympus IX70 inverted 
microscope. 
15. Repeat steps # 9 - #14 for wells #3 - #8.  Stagger the incubations for each dish by 
30 minutes to so that calcium waves can be imaged while the cells in each dish 
are still freshly loaded with Fura-2 AM. 
 
 
Figure 6 (calcium waves – SR protocol)  
 
 Note:  The SFCF protocol (see above protocol) was used in the experiment for the 20 
hour & 32 hour time points, where as the SR protocol was used in the experiment for 
the 40 hour & 50 hour time points. 
1.   Obtain 1-60 mm dish containing confluent SCN2.2 cells. 
2.   Expand the dish to 4 glass coverslip bottom dishes (2 chamber wells per dish). 
During expansion, suspend the pellet of cells in SCN media containing 5% FBS 
(instead of the usual 10% FBS).  The SCN media added to each well should also 
contain 5% FBS.  Label the wells #1 - #8.  *Note that this step serves as the first 
serum reduction event as well as the plating event (time 0).  From this step, at 
time 0, cells can be carried out to 40 hours or 50 hours depending on the desired 
time point.  Calcium waves are imaged at 40 hours or 50 hours from time 0. 
Place the cells in 37ºC incubator containing 5% CO2 for exactly 24 hours. 
3. After 24 hours, remove all wells from incubator and discard media.  
Wash each well twice with neurobasal media.  Add 2 ml neurobasal media to 
each well.  *Note that this step serves as the final serum reduction event. 
Place all wells in 37ºC incubator. 
4. Two hours prior to imaging (i.e. desired time point), begin Fura-2 AM 
incubations.  Remove wells #1 - #4 from incubator.  Wash each well two times 
with neurobasal media.  Add 2 ml of 8 µM Fura-2 AM calcium indicator solution 
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to each well.  See protocol for Fig. 3 & 4 step #6 for calcium indicator solution 
preparation.  Incubate wells #1 - #4 for 1 hour at 37ºC.   
5. Remove wells #1 - #4 from incubator.  Wash each well five times with 
neurobasal media.  Add 2 ml neurobasal media to each well.  Place wells #1 - #4 
in 37ºC incubator for 1 hour to recover. 
6. Remove wells #1 - #4 from incubator and collect a 500 µl media sample from 
each well and freeze sample at -20ºC. 
7. Image calcium waves for wells #1 - #4 using an Olympus IX70 inverted 
microscope. 
8. Repeat steps #4 - #7 for wells #5 - #8.  Note that the Fura-2 AM incubations are 
staggered to use cells that have been freshly loaded with calcium indicator. 
  
 
Figure 7 (2-NBDG uptake) 
  
1.   Obtain 1-60 mm dish containing confluent SCN2.2 cells. 
2.   Expand the dish to 4 glass coverslip bottom dishes (2 chamber wells per dish). 
 During expansion, suspend the pellet of cells in SCN media containing 5% FBS 
(instead of the usual 10% FBS).  The SCN media added to each well should also 
contain 5% FBS.  Label the wells #1 - #8.  *Note that this step serves as the first 
serum reduction event as well as the plating event (time 0).  From this step, at 
time 0, cells can be carried out to 40 hours or 50 hours depending on the desired 
time point.  Place all wells in 37ºC incubator containing 5% CO2 for exactly 24 
hours. 
9. After 24 hours, remove all wells from incubator and discard media.  
Wash each well twice with neurobasal media.  Add 2 ml neurobasal media to 
each well.  *Note that this step serves as the final serum reduction event. 
Place all wells in 37ºC incubator. 
10. Thirty minutes prior to desired time point (e.g., 40 hours), 
Remove wells #1 - #4 from incubator.  Wash each well twice with neurobasal 
media.  Immediately continue to next step. 
11. Next, perform treatment specific washes.  Wash wells #1 & #3 twice with 
neurobasal media.  Then, wash wells #2 & #4 twice with neurobasal media 
containing no glucose. 
12. Begin 2-NBDG incubations: 
Add 2 ml of 0.1 mM 2-NBDG in neurobasal media to wells #1 & #3. 
Add 2 ml of 0.1 mM 2-NBDG in neurobasal media containing no glucose to 
wells #2 & #4.  
13. Incubate wells #1 - #4 for 1 hour at 37ºC (dark). 
14. Remove wells #1 - #4 from incubator and wash each well five times with 
neurobasal media.  Pop off sides of chamber wells and prepare a glass wet mount 
slide for each glass coverslip bottom dish. 
15. Immediately image cells with Olympus IX70 inverted microscope. 
16. Repeat steps # 10 - #15 for next desired time point (e.g., 50 hours).   
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Figure 8 (calcium waves) 
 
The protocol followed for the experiment in Figure 8 was identical to the SR 
protocol for Figure 6.  However, melatonin (10 nM) and ATP (10 nM) treatments 
were added during the Fura-2 AM loading period and/or recovery period.     
 
 
Figure 9 (calcium waves & melatonin dose-dependence) 
 
 The protocol followed for the experiment in Figure 9 was identical to the SR 
protocol for Figure 6.  However, melatonin (10 fM; 10 pM; 10 nM) and luzindole 
(100 nM; 10 µM) treatments were added during the one hour recovery period.    
 
Figure 10 (calcium waves) 
  
Note: This protocol contains time points to target low and high levels of endogenous 
extracellular ATP. 
1.   Obtain 1-60 mm dish containing confluent SCN2.2 cells. 
2.   Expand the dish to 4 glass coverslip bottom dishes (2 chamber wells per dish). 
During expansion, suspend the pellet of cells in SCN media containing 5% FBS 
(instead of the usual 10% FBS).  The SCN media added to each well should also 
contain 5% FBS.   
*Note that this step serves as the first serum reduction event. 
Place the cells in 37ºC incubator containing 5% CO2 until the cell cultures reach 
50% confluence.  This usually takes 24 hours. 
16. At 34 hours prior to imaging, remove all wells from incubator.   
Wash each well twice with CMF. 
Add 2 ml neurobasal media (contains neurobasal medium along with B-27 
supplement, L-glutamine, and glucose) to each well. 
*Note that this step serves as the final serum reduction event. 
Label the wells #1 - #8 and place back in 37ºC incubator. 
17. Remove wells #1 - #4 from incubator. 
Add 2 µl of 15 mM forskolin in 100% DMSO (final concentration of 15 µM FSK 
in 0.1% DMSO) to each well.  Pipette to mix. 
Note: first remove 2 µl of media from well and discard before adding the FSK. 
Incubate wells #1 - #4 at 37ºC for 2 hours. 
This serves as the FSK pulse for the 32 hour time point.  
18. After 2 hours, remove wells #1 - #4 from incubator and wash each well twice 
with CMF.  Add 2 ml neurobasal media to each well.  Place wells in 37ºC 
incubator. This step serves as time 0 for the 32 hour time point. 
19. At 22 hours prior to imaging, remove wells #5 - #8 from incubator. 
Wash each well twice with CMF and add 2 ml neurobasal media to each well. 
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Add 2 µl of 15 mM FSK in 100% DMSO (final concentration of 15 µM FSK in 
0.1% DMSO) to each well.  Remember to first remove 2 µl of media and discard 
before adding the FSK to each well.  Pipette to mix. 
Incubate wells #5 - #8 at 37ºC for 2 hours. 
This serves as the FSK pulse for the 20 hour time point. 
20. After 2 hours, remove wells #5 - #8 from incubator and wash each well twice 
with CMF.  Add 2 ml neurobasal media to each well.  Place wells in 37ºC 
incubator. This step serves as time 0 for the 20 hour time point. 
21. Note that the 32 hour and 20 hour time points are created by counting backwards 
from the actual time that calcium waves are imaged.  This allows calcium wave 
imaging to be performed simultaneously for both time points. 
22. At 2 hours prior to imaging, begin Fura-2 AM incubations.  See protocol for Fig. 
3 & 4 step #6 for calcium indicator solution preparation. 
23. Remove wells #1 & #2 from incubator and wash each well twice with CMF.  
Add 1.5 ml Fura-2 AM calcium indicator solution to each well.  Incubate wells at 
37ºC for 1 hour. 
24. Remove wells #1 & #2 from incubator.  Wash each well three times with 
neurobasal media.  Add 2 ml neurobasal media to each well.  
Now, begin treatment of DMSO (control) or melatonin. 
Add 2 µl of 100% DMSO (0.1% DMSO final concentration) to well #1.  Pipette 
to mix.  Again, first remove 2 µl of media before adding the DMSO. 
Add 2 µl of 10 µM melatonin in 100% DMSO (10 nM Mel in 0.1 % DMSO final 
concentration) to well #2. Pipette to mix.  Remember to remove 2 µl of media 
and discard media before adding the melatonin to keep concentrations correct.   
25. Place wells #1 & #2 in 37ºC for 1 hour for treatment and recovery period. 
26. After 1 hour, collect a 1 ml media sample from each well and place in -20ºC 
freezer.   
27. Image calcium waves for wells #1 & #2 using an Olympus IX70 inverted 
microscope. 
28. Repeat steps # 9 - #14 for wells #3 - #8.  Stagger the incubations for each dish by 
30 minutes to so that calcium waves can be imaged while the cells in each dish 
are still freshly loaded with Fura-2 AM.  The DMSO treatments are for the odd 
numbered wells and the melatonin treatments are for the even numbered wells.  
Therefore, each dish contains a control and melatonin well to be imaged 
immediately following each other. 
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